RemeGen Biosciences
Pallavi Panth, MD (MBBS), PhD, currently serves as a Clinical Trial Manager in Global Clinical Development at RemeGen Biosciences since September 2023. Parallelly, Pallavi Panth engages in academic contributions as an Ad Hoc Peer-Reviewer for Cambridge University Press, BMC, and Population Medicine, as well as an Editorial Board Member for Springer N. Previous experience includes roles as a Clinical Research Associate at Medpace and DOCS, and as a Clinical Research Program Coordinator at Southern Endocrinology Associates PA, managing clinical trials in various therapeutic areas. As an adjunct faculty member at Texas Woman's University, Pallavi Panth delivered didactic lectures on biochemistry and metabolic processes while also conducting dissertation research in endocrinology and metabolic diseases. Educational qualifications include a PhD in Nutrition Sciences and an M.S. in Clinical Nutrition from Texas Woman's University, along with an MBBS from Gandhi Medical College.
This person is not in any offices
RemeGen Biosciences
1 followers
RemeGen is a global biopharmaceutical company, focusing on the discovery, development and commercialization of novel biologics for the treatment of autoimmune, oncology and ophthalmic diseases with significant unmet medical needs. RemeGen Biosciences, a wholly owned subsidiary of RemeGen, is based in South San Francisco, California, the birthplace of biotechnology and in Maryland. Our vision is to create the first-in-class and/or best-in-class biotherapeutics with innovative target discovery strategies, advanced molecule design and protein engineering platforms. Our passion is to serve patients with more effective therapies in a timely manner.